30042 related articles for article (PubMed ID: 10388011)
41. Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Struewing JP; Watson P; Easton DF; Ponder BA; Lynch HT; Tucker MA
J Natl Cancer Inst Monogr; 1995; (17):33-5. PubMed ID: 8573450
[TBL] [Abstract][Full Text] [Related]
42. [Familial cancer of the colon without polyposis and the familial cancer syndrome. Apropos of 2 cases over 3 generations].
Poissonnier M; Andrieu J; Gardon JD; Saint-Martin JL; Gruyer P; Martignon C
J Genet Hum; 1983 Dec; 31(4):255-78. PubMed ID: 6663287
[TBL] [Abstract][Full Text] [Related]
43. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
44. [Adenocarcinoma of the prostate].
Dvorácek J
Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
[TBL] [Abstract][Full Text] [Related]
45. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
[TBL] [Abstract][Full Text] [Related]
46. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
47. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract][Full Text] [Related]
48. The role of prophylactic oophorectomy in cancer prevention.
Averette HE; Nguyen HN
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S38-41. PubMed ID: 7835808
[TBL] [Abstract][Full Text] [Related]
49. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
50. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
51. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
[TBL] [Abstract][Full Text] [Related]
52. Hereditary aspects of prostate cancer.
McLellan DL; Norman RW
CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
[TBL] [Abstract][Full Text] [Related]
53. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
[TBL] [Abstract][Full Text] [Related]
54. [Familial history of ovarian carcinoma: policy].
de Hullu JA; Kets CM; Massuger LF; Ligtenberg ML; van Ham MA; Hoogerbrugge N
Ned Tijdschr Geneeskd; 2011; 155():A2392. PubMed ID: 21262027
[TBL] [Abstract][Full Text] [Related]
55. [Some insufficiently recognized risk factors for breast cancer].
Kocić B; Janković S; Petrović B; Tiodorović B
Srp Arh Celok Lek; 1996; 124(7-8):175-8. PubMed ID: 9102842
[TBL] [Abstract][Full Text] [Related]
56. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group.
Gruber SB; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):411-7. PubMed ID: 8781735
[TBL] [Abstract][Full Text] [Related]
57. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by consultant gynaecologists in Ireland.
Geary M; Geoghegan A; Foley M
Ir Med J; 1997; 90(5):186-7. PubMed ID: 9345830
[TBL] [Abstract][Full Text] [Related]
58. Osteoporosis: new hope for the future.
Masi L; Bilezikian JP
Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
[TBL] [Abstract][Full Text] [Related]
59. Incidence of ovarian cancer in women with prior hysterectomy in Japan.
Yaegashi N; Sato S; Yajima A
Gynecol Oncol; 1998 Mar; 68(3):244-6. PubMed ID: 9570974
[TBL] [Abstract][Full Text] [Related]
60. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
